Mammary gland neoplasia

Environmental Health Perspectives

Volumn 104, Issue 9, 1996, Pages 912-914

  Neumann, David A ^a   Crisp, Thomas M ^b   Olin, Stephen S ^a  

^a ILSI Risk Science Institute   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Breast cancer; Chemical carcinogens; Estrogen; Hormones; Interspecies extrapolation; Mammary tumors; Risk assessment; Rodent bioassay

Indexed keywords

ESTROGEN; HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; HUMAN; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SHORT SURVEY; SPECIES DIFFERENCE;

ANIMALIA; RODENTIA;

EID: 0029825724     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.96104912     Document Type: Short Survey

References (13)

1. Russo IH, Russo J. Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect 104:938-967 (1996).
2. Haseman JK. Statistical considerations in long-term dietary restriction studies. In: Dietary restriction: implications for the design and interpretation of toxicity and carcinogenicity studies (Hart RW, Neumann DA, Robertson RT, eds). Washington:ILSI Press, 1995; 141-153.
3. Miller BA, Feuer EJ, Hankey BF. The significance of the rising incidence of breast cancer in the United States. In: Important advances in oncology (DeVito VT, Hellman S, Rosenberg JB, eds). Philadelphia:Lippincott Co., 1994; 193-207.
4. Henderson JC. Risk factors for breast cancer development. Cancer Suppl 71:2127-2140 (1993).
5. Korenman SG. Oestrogen window hypothesis of the aetiology of breast cancer. Lancet 1:700-701 (1980).
6. Langston AA, Malone KE, Thompson JD, Daling JR, Ostrander EA. BRCA1 mutations in a population-based sample of young women with breast cancer. N Engl J Med 334:137-142 (1996).
7. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265:2088-2090 (1994).
8. Barrett JC. Mechanisms for species differences in receptor-mediated carcinogenesis. Mutat Res 333:189-202 (1995).
9. Montano MM, Ekena K, Krueger KD, Keller AL, Katzenellenbogen BS. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens. Mol Endocrinol 10:230-242 (1996).
10. Hatch M, Thomas D. Measurement issues in environmental epidemiology. Environ Health Perspect 101(suppl 4):49-57 (1993).
11. Gould MN. Cellular and molecular aspects of the multistage progression of mammary carcinogenesis in human and rats. Semin Cancer Biol 4:161-169 (1993).
12. Sobels FH. Approaches to assessing genetic risks from exposure to chemicals. Environ Health Perspect 101(suppl 3):327-332 (1993).
13. Soto AM, Sonnenschein C. The role of estrogens on the proliferation of human breast tumor cells (MCF-7). J Steroid Biochem 23:87-94 (1985).